The global bone cement & glue market, which was valued at US$1,644 million in 2023, is on a steady upward trajectory. Industry forecasts indicate that the market will reach a valuation of US$2,248 million by the end of 2028, growing at a resilient compound annual growth rate (CAGR) of 6.5%. This growth is primarily fueled by a sharp increase in road traffic accidents and a rising volume of complex surgical procedures worldwide. Additionally, the rapid expansion of the geriatric population, particularly in regions like North America and Asia Pacific, has created a sustained demand for joint replacement and trauma-related interventions. While extensive clinical data requirements for new product launches remain a significant hurdle, the market continues to evolve through technological advancements and the increasing adoption of specialized materials in clinical settings.
Surging Incidences of Sports Injuries and Physical Activity
The modern emphasis on active lifestyles has inadvertently led to a significant spike in sports-related trauma, becoming a cornerstone driver for the bone cement and glue sector. In the United States alone, approximately 30 million children and adolescents participate in organized sports, resulting in over 3.5 million injuries annually. High-impact activities, ranging from traditional high school athletics to the burgeoning popularity of sports like pickleball—which is estimated to cost Americans USD 377 million in healthcare expenses this year—are placing immense pressure on orthopedic departments. Common injuries affecting the hip, knee, and shoulder often necessitate arthroplasty, where bone cement is essential for anchoring prosthetic implants to the natural bone.
Beyond the United States, the trend is mirrored globally. In Europe, the “Big Five” football leagues saw injury costs rise by 29% in recent seasons, reaching over £513 million. These injuries frequently involve fractures or joint degradations that require the structural support provided by Polymethyl methacrylate (PMMA) or calcium phosphate cements. As participation in competitive and recreational fitness continues to rise, the medical device industry is responding by developing more robust and bio-compatible adhesives to ensure faster recovery times for athletes and active individuals, thereby cementing the market’s long-term growth potential.
Advancements in Minimally Invasive Surgery and Material Innovation
One of the most transformative opportunities in the current landscape is the rising demand for minimally invasive surgeries (MIS). Patients and healthcare providers are increasingly favoring procedures that offer smaller incisions, reduced scarring, and significantly faster rehabilitation periods. Bone cement and glue play a pivotal role in these techniques, particularly in kyphoplasty and vertebroplasty, where they are used to stabilize spinal fractures. Data from the Healthcare Cost and Utilization Project reveals a substantial shift toward MIS, with inpatient cases nearly tripling over the last two decades. The cost-effectiveness of these procedures is a major selling point; for instance, reducing a hospital stay by just one day through MIS can save approximately USD 1,500 in direct costs.
In tandem with surgical technique evolution, material science is redefining product segments. The PMMA segment remains a dominant force due to its reliability in total hip and knee arthroplasty. However, there is a growing shift toward antibiotic-loaded bone cements. These specialized products provide localized therapy, releasing agents like gentamicin or vancomycin directly at the surgical site to mitigate the risk of post-operative infection. Simultaneously, the natural bone glue segment is expected to see the highest growth rate among adhesives. Its superior biocompatibility and biodegradability reduce the body’s foreign response, facilitating natural healing and appealing to a medical community focused on long-term patient outcomes and reduced complications.
Regional Dominance and the Competitive Landscape
Geographically, North America currently holds the largest share of the bone cement and glue market. This dominance is supported by a well-established healthcare infrastructure, high awareness regarding advanced orthopedic treatments, and the presence of major industry players such as Stryker, Zimmer Biomet, and DePuy Synthes. The region’s growth is further bolstered by continuous investments from hospitals to upgrade surgical suites and expand their capacity for geriatric care. However, the Asia Pacific region, led by India, is emerging as the fastest-growing market. India’s surge is attributed to a booming medical tourism sector and an aging population that is increasingly susceptible to orthopedic ailments.
The competitive environment is characterized by strategic consolidations and a focus on specialized portfolios. Recent developments, such as Smith+Nephew acquiring Integra LifeSciences’ extremity orthopedics business and Zimmer Biomet spinning off its spine and dental segments into ZimVie, highlight a trend toward streamlined, expert-driven operations. While market leaders continue to innovate, they face challenges including thermal necrosis risks during polymerization and the high costs associated with meeting stringent FDA clinical data requirements. Despite these hurdles, the integration of surgical robotics and the expansion of Ambulatory Surgical Centers (ASCs) as primary end-users suggest a robust future for the global bone cement and glue industry through 2028 and beyond.